相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Chronic Myeloid Leukemia: A Model Disease of the Past, Present and Future
Valentina R. Minciacchi et al.
CELLS (2021)
Phase III, Randomized, Placebo-Controlled Trial of CC-486 (Oral Azacitidine) in Patients With Lower-Risk Myelodysplastic Syndromes
Guillermo Garcia-Manero et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia
A. Hochhaus et al.
LEUKEMIA (2020)
Evidence of BCR-ABL1-positive progenitor spread in blood during molecular recurrence after TKI discontinuation in chronic myeloid leukemia (CML)
Ali G. Turhan et al.
LEUKEMIA & LYMPHOMA (2020)
An integrative model of pathway convergence in genetically heterogeneous blast crisis chronic myeloid leukemia
Tun Kiat Ko et al.
BLOOD (2020)
Response and Resistance to BCR-ABL1-Targeted Therapies
Theodore P. Braun et al.
CANCER CELL (2020)
DNA methylation disruption reshapes the hematopoietic differentiation landscape
Franco Izzo et al.
NATURE GENETICS (2020)
Phase I/II study of dasatinib in combination with decitabine in patients with accelerated or blast phase chronic myeloid leukemia
Yasmin Abaza et al.
AMERICAN JOURNAL OF HEMATOLOGY (2020)
Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission
A. H. Wei et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Widespread Aberrant Alternative Splicing despite Molecular Remission in Chronic Myeloid Leukaemia Patients
Ulf Schmitz et al.
CANCERS (2020)
The leukaemia stem cell: similarities, differences and clinical prospects in CML and AML
David Vetrie et al.
NATURE REVIEWS CANCER (2020)
Is There an Entity of Radiation-Induced Chronic Myeloid Leukemia? Report of a Case and Brief Review of the Literature
Isao Miyoshi et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY (2020)
Mutation accumulation in cancer genes relates to nonoptimal outcome in chronic myeloid leukemia
Shady Adnan Awad et al.
BLOOD ADVANCES (2020)
Dnmt1 links BCR-ABLp210 to epigenetic tumor stem cell priming in myeloid leukemia
Carolina Vicente-Duenas et al.
LEUKEMIA (2019)
The Roles of Human DNA Methyltransferases and Their Isoforms in Shaping the Epigenome
Hemant Gujar et al.
GENES (2019)
Hereditary myeloid malignancies
Hind Rafei et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2019)
Somatic variants in epigenetic modifiers can predict failure of response to imatinib but not to second-generation tyrosine kinase inhibitors
Georgios Nteliopoulos et al.
HAEMATOLOGICA (2019)
Laying the foundation for genomically-based risk assessment in chronic myeloid leukemia
Susan Branford et al.
LEUKEMIA (2019)
SOX30 methylation correlates with disease progression in patients with chronic myeloid leukemia
Ting-Juan Zhang et al.
ONCOTARGETS AND THERAPY (2019)
Epigenetic Reprogramming and Emerging Epigenetic Therapies in CML
Jane Bugler et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)
Transcriptional alterations in glioma result primarily from DNA methylation-independent mechanisms
Franck Court et al.
GENOME RESEARCH (2019)
Improved precision of epigenetic clock estimates across tissues and its implication for biological ageing
Qian Zhang et al.
GENOME MEDICINE (2019)
BCR-ABL Independent Mechanisms of Resistance in Chronic Myeloid Leukemia
Federica Loscocco et al.
FRONTIERS IN ONCOLOGY (2019)
DNA methylation GrimAge strongly predicts lifespan and healthspan
Ake T. Lu et al.
AGING-US (2019)
CancerClock: A DNA Methylation Age Predictor to Identify and Characterize Aging Clock in Pan-Cancer
Tongtong Zhu et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2019)
Insights into novel emerging epigenetic drugs in myeloid malignancies
Namrata S. Chandhok et al.
THERAPEUTIC ADVANCES IN HEMATOLOGY (2019)
DNA methylation aging clocks: challenges and recommendations
Christopher G. Bell et al.
GENOME BIOLOGY (2019)
Epigenetic dysregulation in chronic myeloid leukaemia: A myriad of mechanisms and therapeutic options
Steffen Koschmieder et al.
SEMINARS IN CANCER BIOLOGY (2018)
An epigenetic biomarker of aging for lifespan and healthspan
Morgan E. Levine et al.
AGING-US (2018)
Aberrant DNA Methylation in Chronic Myeloid Leukemia: Cell Fate Control, Prognosis, and Therapeutic Response
Masumeh Maleki Behzad et al.
BIOCHEMICAL GENETICS (2018)
Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high-risk disease
Susan Branford et al.
BLOOD (2018)
Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial
Susanne Saussele et al.
LANCET ONCOLOGY (2018)
Frequent ASXL1 mutations in children and young adults with chronic myeloid leukemia
Thomas Ernst et al.
LEUKEMIA (2018)
DNA methylation profiling reveals a pathological signature that contributes to transcriptional defects of CD34+CD15- cells in early chronic-phase chronic myeloid leukemia
Stephanie Maupetit-Mehouas et al.
MOLECULAR ONCOLOGY (2018)
Somatic mutations precede myeloid leukemia years before diagnosis
Pinkal Desai et al.
NATURE MEDICINE (2018)
Epigenetic deregulation in chronic lymphocytic leukemia: Clinical and biological impact
Larry Mansouri et al.
SEMINARS IN CANCER BIOLOGY (2018)
Prediction of acute myeloid leukaemia risk in healthy individuals
Sagi Abelson et al.
NATURE (2018)
Spectrum of somatic mutation dynamics in chronic myeloid leukemia following tyrosine kinase inhibitor therapy
TaeHyung Kim et al.
BLOOD (2017)
Imatinib discontinuation in chronic myeloid leukaemia patients with undetectable BCR-ABL transcript level: A systematic review and a meta-analysis
Leonardo Campiotti et al.
EUROPEAN JOURNAL OF CANCER (2017)
Long-Term Follow-Up of the French Stop Imatinib (STIM1) Study in Patients With Chronic Myeloid Leukemia
Gabriel Etienne et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease
S. Jaiswal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Frequent somatic mutations in epigenetic regulators in newly diagnosed chronic myeloid leukemia
E. Togasaki et al.
BLOOD CANCER JOURNAL (2017)
DNMT3A and TET2 dominate clonal hematopoiesis and demonstrate benign phenotypes and different genetic predispositions
Manuel Buscarlet et al.
BLOOD (2017)
DNA methylation-based measures of biological age: meta-analysis predicting time to death
Brian H. Chen et al.
AGING-US (2016)
Risk stratification of chromosomal abnormalities in chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy
Wei Wang et al.
BLOOD (2016)
DNA Methylation Dynamics of Human Hematopoietic Stem Cell Differentiation
Matthias Farlik et al.
CELL STEM CELL (2016)
Next-generation sequencing identifies major DNA methylation changes during progression of Ph plus chronic myeloid leukemia
G. Heller et al.
LEUKEMIA (2016)
DNA methylation dynamics during B cell maturation underlie a continuum of disease phenotypes in chronic lymphocytic leukemia
Christopher C. Oakes et al.
NATURE GENETICS (2016)
Genetic predisposition to leukemia and other hematologic malignancies
Simone Feurstein et al.
SEMINARS IN ONCOLOGY (2016)
Epigenetic Determinants of Cancer
Stephen B. Baylin et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2016)
Leukemic stem cell persistence in chronic myeloid leukemia patients in deep molecular response induced by tyrosine kinase inhibitors and the impact of therapy discontinuation
Jean Claude Chomel et al.
ONCOTARGET (2016)
Bcr-abl regulates Stat5 through Shp2, the interferon consensus sequence binding protein (Icsbp/Irf8), growth arrest specific 2 (Gas2) and calpain
Elizabeth E. Hjort et al.
ONCOTARGET (2016)
Natural course and biology of CML
Bradley Chereda et al.
ANNALS OF HEMATOLOGY (2015)
The Implication of Cancer Progenitor Cells and the Role of Epigenetics in the Development of Novel Therapeutic Strategies for Chronic Myeloid Leukemia
Stephanie M. Tortorella et al.
ANTIOXIDANTS & REDOX SIGNALING (2015)
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
David P. Steensma et al.
BLOOD (2015)
The EUTOS population-based registry: incidence and clinical characteristics of 2904 CML patients in 20 European Countries
V. S. Hoffmann et al.
LEUKEMIA (2015)
Dissecting the role of aberrant DNA methylation in human leukaemia
Giovanni Amabile et al.
NATURE COMMUNICATIONS (2015)
A B-cell epigenetic signature defines three biologic subgroups of chronic lymphocytic leukemia with clinical impact
A. C. Queiros et al.
LEUKEMIA (2015)
Methylation status of CEBPA gene promoter in chronic myeloid leukemia
Sandhya Annamaneni et al.
HEMATOLOGY (2014)
Origins of aberrant DNA methylation in acute myeloid leukemia
T. Schoofs et al.
LEUKEMIA (2014)
Molecular-defined clonal evolution in patients with chronic myeloid leukemia independent of the BCR-ABL status
M. Schmidt et al.
LEUKEMIA (2014)
Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia
Liran I. Shlush et al.
NATURE (2014)
Age-related mutations associated with clonal hematopoietic expansion and malignancies
Mingchao Xie et al.
NATURE MEDICINE (2014)
Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence
Giulio Genovese et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
Siddhartha Jaiswal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Methylation and decreased expression of SHP-1 are related to disease progression in chronic myelogenous leukemia
Yinghua Li et al.
ONCOLOGY REPORTS (2014)
Evolution of DNA Methylation Is Linked to Genetic Aberrations in Chronic Lymphocytic Leukemia
Christopher C. Oakes et al.
CANCER DISCOVERY (2014)
Genome-wide Methylation Profiles Reveal Quantitative Views of Human Aging Rates
Gregory Hannum et al.
MOLECULAR CELL (2013)
Cell of origin determines clinically relevant subtypes of MLL-rearranged AML
A. V. Krivtsov et al.
LEUKEMIA (2013)
DNA methylation: roles in mammalian development
Zachary D. Smith et al.
NATURE REVIEWS GENETICS (2013)
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
Timothy J. Ley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Role of Epigenetics in Chronic Myeloid Leukemia
Katerina Machova Polakova et al.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2013)
HOXA4 Gene Promoter Hypermethylation as an Epigenetic Mechanism Mediating Resistance to Imatinib Mesylate in Chronic Myeloid Leukemia Patients
Marjanu Hikmah Elias et al.
BIOMED RESEARCH INTERNATIONAL (2013)
DNA methylation age of human tissues and cell types
Steve Horvath
GENOME BIOLOGY (2013)
Occupational benzene exposure and the risk of chronic myeloid leukemia: A meta-analysis of cohort studies incorporating study quality dimensions
Jelle Vlaanderen et al.
AMERICAN JOURNAL OF INDUSTRIAL MEDICINE (2012)
Quantitative modeling of chronic myeloid leukemia: insights from radiobiology
Tomas Radivoyevitch et al.
BLOOD (2012)
The Origin and Evolution of Mutations in Acute Myeloid Leukemia
John S. Welch et al.
CELL (2012)
Down-regulation of hematopoiesis master regulator PU.1 via aberrant methylation in chronic myeloid leukemia
Hui Yang et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2012)
IDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigenetics
Masato Sasaki et al.
NATURE (2012)
Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis
Lambert Busque et al.
NATURE GENETICS (2012)
Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia
Marta Kulis et al.
NATURE GENETICS (2012)
Functions of DNA methylation: islands, start sites, gene bodies and beyond
Peter A. Jones
NATURE REVIEWS GENETICS (2012)
Base-Pair Resolution DNA Methylation Sequencing Reveals Profoundly Divergent Epigenetic Landscapes in Acute Myeloid Leukemia
Altuna Akalin et al.
PLOS GENETICS (2012)
CBL, CBLB, TET2, ASXL1, and IDH1/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemia
Hideki Makishima et al.
BLOOD (2011)
Genome-wide promoter DNA methylation dynamics of human hematopoietic progenitor cells during differentiation and aging
Michael T. Bocker et al.
BLOOD (2011)
Thymine DNA Glycosylase Is Essential for Active DNA Demethylation by Linked Deamination-Base Excision Repair
Salvatore Cortellino et al.
CELL (2011)
Mutation analysis of TET2, IDH1, IDH2 and ASXL1 in chronic myeloid leukemia
C. Roche-Lestienne et al.
LEUKEMIA (2011)
A deep-sequencing study of chronic myeloid leukemia patients in blast crisis (BC-CML) detects mutations in 76.9% of cases
V. Grossmann et al.
LEUKEMIA (2011)
Increased methylation variation in epigenetic domains across cancer types
Kasper Daniel Hansen et al.
NATURE GENETICS (2011)
Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia
Xiao-Jing Yan et al.
NATURE GENETICS (2011)
Aberrant DNA Methylation Is Associated with Disease Progression, Resistance to Imatinib and Shortened Survival in Chronic Myelogenous Leukemia
Jaroslav Jelinek et al.
PLOS ONE (2011)
Tet Proteins Can Convert 5-Methylcytosine to 5-Formylcytosine and 5-Carboxylcytosine
Shinsuke Ito et al.
SCIENCE (2011)
Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials
David Grimwade et al.
BLOOD (2010)
Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
Maria E. Figueroa et al.
CANCER CELL (2010)
DNA Methylation Signatures Identify Biologically Distinct Subtypes in Acute Myeloid Leukemia
Maria E. Figueroa et al.
CANCER CELL (2010)
Exposure to benzene at work and the risk of leukemia: a systematic review and meta-analysis
Abdul Khalade et al.
ENVIRONMENTAL HEALTH (2010)
Methylation patterns in CD34 positive chronic myeloid leukemia blast crisis cells
Jeroen J. W. M. Janssen et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
A Genome-wide screen identifies frequently methylated genes in haematological and epithelial cancers
Thomas Dunwell et al.
MOLECULAR CANCER (2010)
BCR-ABL: a multi-faceted promoter of DNA mutation in chronic myelogeneous leukemia
B. A. Burke et al.
LEUKEMIA (2010)
Comprehensive methylome map of lineage commitment from haematopoietic progenitors
Hong Ji et al.
NATURE (2010)
Reprogramming towards pluripotency requires AID-dependent DNA demethylation
Nidhi Bhutani et al.
NATURE (2010)
Epigenetic down-regulation of BIM expression is associated with reduced optimal responses to imatinib treatment in chronic myeloid leukaemia
Edurne San Jose-Eneriz et al.
EUROPEAN JOURNAL OF CANCER (2009)
Aberrant methylation of the death-associated protein kinase 1 (DAPK1) CpG island in chronic myeloid leukemia
Jun Qian et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2009)
Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1
Mamta Tahiliani et al.
SCIENCE (2009)
Hypomethylation of PRAMS is responsible for its aberrant overexpression in human malignancies
Tino Schenk et al.
GENES CHROMOSOMES & CANCER (2007)
Phase II study of low-dose decitabine in combination with imatinib mesylate in patients with accelerated or myeloid blastic phase of chronic myelogenous leukemia
Yasuhiro Oki et al.
CANCER (2007)
Inactivation of HOXA genes by hypermethylation in myeloid and lymphoid malignancy is frequent and associated with poor prognosis
Gordon Strathdee et al.
CLINICAL CANCER RESEARCH (2007)
Dose-dependent effects of Bcr-Abl in cell line models of different stages of chronic myeloid leukemia
DJ Barnes et al.
ONCOGENE (2005)
Phase II study of low-dose decitabine in patients with chronic myelogenous leukemia resistant to imatinib mesylate
JPJ Issa et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2′-deoxycytidine (decitabine) in hematopoietic malignancies
JPJ Issa et al.
BLOOD (2004)
Results of decitabine (5-Aza-2′deoxycytidine) therapy in 130 patients with chronic myelogenous leukemia
HM Kantarjian et al.
CANCER (2003)
WT1 in acute leukemia, chronic myelogenous leukemia and myelodysplastic syndrome: therapeutic potential of WT1 targeted therapies
C Rosenfeld et al.
LEUKEMIA (2003)
BCR/ABL regulates response to DNA damage: the role in resistance to genotoxic treatment and in genomic instability
T Skorski
ONCOGENE (2002)
Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro
SM Graham et al.
BLOOD (2002)
Cytogenetic and molecular genetic evolution of chronic myeloid leukemia
B Johansson et al.
ACTA HAEMATOLOGICA (2002)
Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia.
BJ Druker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
分享论文
